The combination of curcumin and dasatinib demonstrated synergistic effects on the suppression of growth factor receptors (EGFR and IGF-1R) and non-receptor (c-Src) signaling to induce growth inhibition on multiple CRC cell lines [107]. Here, EGFR is linked to colorectal carcinoma.